University of Pittsburgh - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

University of Pittsburgh - Pharmaceuticals & Healthcare - Deals and Alliances Profile

University of Pittsburgh - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
University of Pittsburgh - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
41 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

University of Pittsburgh (Pitt) is an educational research institute that offers undergraduate, graduate and professional programs. The institute provides academic courses in different fields such as business, information sciences, health and rehabilitation, information sciences, engineering, environmental and occupational health, epidemiology, nursing, pharmacy, arts, social sciences, law, medicine, public and international affairs. It conducts research in the areas which include aging, bioengineering, computer modeling, drug discovery, global health, humanities, international studies, energy, nanoscience, neuroscience, philosophy and translational medicine.

University of Pittsburgh - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

  
Source:
Document ID
GDPH39030D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
University of Pittsburgh, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
University of Pittsburgh, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
University of Pittsburgh, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
University of Pittsburgh, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
University of Pittsburgh, Medical Devices Deals, 2010 to YTD 201691
University of Pittsburgh, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016102
University of Pittsburgh, Pharmaceuticals &Healthcare, Deal Details1224
  Venture Financing121
    Evolent Health Raises US$101.3 Million In Series B Financing122
  Partnerships141
    University of Pittsburgh Cancer Institute Enters into Contract with National Cancer Institute141
    American Gene Technologies Partners with University of Pittsburgh151
    NanoViricides Enters into Research Agreement with University of Pittsburgh161
    GeoVax Labs Enters into Research Agreement with University of Pittsburgh171
    CareCore National Enters Into Joint Venture Agreement With UPMC181
    University of Pittsburgh Partners With Battelle, IBM And Merck192
  Merger211
    Jameson Health System to Merge with UPMC211
  Licensing Agreements221
    NuvOx Pharma Enters into Licensing Agreement with University of Pittsburgh221
    Asana Medical Enters into Licensing Agreement with University of Pittsburgh231
    Oxis Biotech Amends Option Agreement with University of Pittsburgh to License Certain Patents241
    Oxis Biotech Enters into Licensing Agreement with University of Pittsburgh251
    DiaVacs Enters into Licensing Agreement with University Of Pittsburgh261
    iBio Enters into Licensing Agreement with University of Pittsburgh271
    Stemline Therapeutics Enters Into Licensing Agreement With University of Pittsburgh For EphA2281
    Stemline Therapeutics Enters Into Licensing Agreement With University of Pittsburgh For SL-701291
    ImmunoCellular Enters Into Licensing Agreement With University of Pittsburgh301
    Horizon Discovery Enters Into Licensing Agreement With University Of Pittsburgh312
    Stemline Therapeutics Enters Into Licensing Agreement With University Of Pittsburgh331
    Hawthorn Pharma Enters Into Licensing Agreement With The University Of Pittsburgh341
  Acquisition351
    MedCare Equipment Acquires Great Lakes Home Healthcare Services From UPMC Hamot351
University of Pittsburgh - Key Competitors361
Key Employees371
Locations And Subsidiaries383
  Head Office381
  Other Locations &Subsidiaries383
Appendix411
  Methodology411
  About GlobalData411
  Contact Us411
  Disclaimer411

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "University of Pittsburgh - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/University-of-Pittsburgh-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-13651>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). University of Pittsburgh - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/University-of-Pittsburgh-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-13651>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research